Silk Road Medical Future Growth
Future criteria checks 1/6
Silk Road Medical is forecast to grow earnings and revenue by 6.2% and 9.8% per annum respectively. EPS is expected to grow by 7.2% per annum. Return on equity is forecast to be -41% in 3 years.
Key information
6.2%
Earnings growth rate
7.2%
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | 9.8% |
| Future return on equity | -41.0% |
| Analyst coverage | Good |
| Last updated | 13 Mar 2024 |
Recent future growth updates
Recent updates
Silk Road Medical, Inc's (NASDAQ:SILK) Shares Leap 35% Yet They're Still Not Telling The Full Story
Feb 03
A Piece Of The Puzzle Missing From Silk Road Medical, Inc's (NASDAQ:SILK) 26% Share Price Climb
Dec 20Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?
Nov 03Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Aug 05Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price
May 05Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Apr 04Silk Road Medical announces $100M common stock offering
Oct 17Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?
Sep 24Silk Road Medical GAAP EPS of -$0.44 beats by $0.02, revenue of $33.17M beats by $2.14M
Jul 26Silk Road Medical: Divergence From Alternative Risk Premia Means Lack Of Upside Capture
Jul 19Silk Road Medical falls after Citigroup downgrades to Sell from Neutral
Jul 11Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?
Jun 09Silk Road Medical - What A Road It Has Been
Apr 08Is Silk Road Medical (NASDAQ:SILK) Using Debt Sensibly?
Feb 23Silk Road Medical, Inc's (NASDAQ:SILK) Intrinsic Value Is Potentially 48% Above Its Share Price
Jan 24Is It Too Late To Consider Buying Silk Road Medical, Inc (NASDAQ:SILK)?
Dec 09Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?
Nov 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 238 | -46 | -7 | -6 | 4 |
| 12/31/2025 | 217 | -50 | -11 | -12 | 9 |
| 12/31/2024 | 196 | -54 | -16 | -14 | 8 |
| 12/31/2023 | 177 | -56 | -34 | -32 | N/A |
| 9/30/2023 | 170 | -55 | -29 | -26 | N/A |
| 6/30/2023 | 163 | -53 | -27 | -24 | N/A |
| 3/31/2023 | 151 | -55 | -33 | -30 | N/A |
| 12/31/2022 | 139 | -55 | -38 | -33 | N/A |
| 9/30/2022 | 127 | -57 | -47 | -41 | N/A |
| 6/30/2022 | 114 | -61 | -50 | -43 | N/A |
| 3/31/2022 | 107 | -56 | -48 | -42 | N/A |
| 12/31/2021 | 101 | -50 | -44 | -39 | N/A |
| 9/30/2021 | 94 | -52 | -44 | -42 | N/A |
| 6/30/2021 | 90 | -48 | -41 | -40 | N/A |
| 3/31/2021 | 78 | -48 | -43 | -42 | N/A |
| 12/31/2020 | 75 | -47 | -43 | -42 | N/A |
| 9/30/2020 | 73 | -39 | -34 | -33 | N/A |
| 6/30/2020 | 70 | -37 | -36 | -35 | N/A |
| 3/31/2020 | 70 | -38 | -33 | -33 | N/A |
| 12/31/2019 | 63 | -52 | -30 | -30 | N/A |
| 9/30/2019 | 56 | -60 | -30 | -30 | N/A |
| 6/30/2019 | 49 | -61 | -31 | -30 | N/A |
| 3/31/2019 | 42 | -56 | -28 | -26 | N/A |
| 12/31/2018 | 35 | -38 | -24 | -22 | N/A |
| 12/31/2017 | 14 | -19 | -26 | -25 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SILK is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SILK is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SILK is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SILK's revenue (9.8% per year) is forecast to grow faster than the US market (7.9% per year).
High Growth Revenue: SILK's revenue (9.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SILK is forecast to be unprofitable in 3 years.